Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Suppression of Endogenous Glucose Production by Injectable HDV-Insulin Lispro: A Dose Response Study in Human Subjects With Type 1 Diabetes

NCT05689424 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT05689424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05689424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Suppression of Endogenous Glucose Production by Injectable HDV-Insulin Lispro: A Dose Response Study in Human Subjects With Type 1 Diabetes
Lead sponsor
University of California, San Diego
Phase
Phase 1
Overall status
Not yet recruiting
Start date
February 1, 2025
Completion date
June 30, 2026
Enrollment
18 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes